Matches in Wikidata for { <http://www.wikidata.org/entity/Q93011458> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q93011458 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q93011458 description "scientific article published on 28 January 2020" @default.
- Q93011458 description "wetenschappelijk artikel" @default.
- Q93011458 description "наукова стаття, опублікована 28 січня 2020" @default.
- Q93011458 name "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 name "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 type Item @default.
- Q93011458 label "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 label "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 prefLabel "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 prefLabel "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 P1433 Q93011458-96263DAF-9FEB-4723-B0D2-D1221A5722C6 @default.
- Q93011458 P1476 Q93011458-74175F30-1F46-4B5F-8097-3E52E2ED8AA9 @default.
- Q93011458 P2093 Q93011458-0CA6F6E1-713B-486F-9A82-9EC6F3A9F5F5 @default.
- Q93011458 P2093 Q93011458-47E6A6BB-568A-4AB7-BA54-5E431D4E35C0 @default.
- Q93011458 P2093 Q93011458-767C5567-1845-4EAD-90BA-E0C656E2189B @default.
- Q93011458 P2093 Q93011458-AD24E7E1-30F9-4405-90DB-FEDA70A83127 @default.
- Q93011458 P2093 Q93011458-F9D75EEC-1907-4DB4-9EC7-D2E5953B9F58 @default.
- Q93011458 P304 Q93011458-8CE330FF-478D-4A2A-A7D7-E87F21A4B1AC @default.
- Q93011458 P31 Q93011458-8FBA74FE-0631-4467-A31D-38835E96D459 @default.
- Q93011458 P356 Q93011458-6B588736-C78E-4B2A-9333-680C93F7BD7F @default.
- Q93011458 P433 Q93011458-68222374-3019-446B-871C-84572D50DBE4 @default.
- Q93011458 P478 Q93011458-25636D6D-5B10-411A-8A7D-C3F79CB6F7E5 @default.
- Q93011458 P577 Q93011458-CB1EF98A-0E32-49C4-A3CA-2CFB4CB77366 @default.
- Q93011458 P698 Q93011458-41042D0D-548D-48CB-9280-F81BBE42609D @default.
- Q93011458 P356 JPET.119.263723 @default.
- Q93011458 P698 31992608 @default.
- Q93011458 P1433 Q1500272 @default.
- Q93011458 P1476 "The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action" @default.
- Q93011458 P2093 "Anna Thorsø Larsen" @default.
- Q93011458 P2093 "Kim Henriksen" @default.
- Q93011458 P2093 "Kim Vietz Andreassen" @default.
- Q93011458 P2093 "Morten Asser Karsdal" @default.
- Q93011458 P2093 "Nina Sonne" @default.
- Q93011458 P304 "92-102" @default.
- Q93011458 P31 Q13442814 @default.
- Q93011458 P356 "10.1124/JPET.119.263723" @default.
- Q93011458 P433 "1" @default.
- Q93011458 P478 "373" @default.
- Q93011458 P577 "2020-01-28T00:00:00Z" @default.
- Q93011458 P698 "31992608" @default.